Details for New Drug Application (NDA): 215612
✉ Email this page to a colleague
NDA 215612 describes FLUOROURACIL, which is a drug marketed by Accord Hlthcare, Dr Reddys Labs Sa, Encube, Extrovis, Taro, Abic, Abraxis Pharm, Alembic, Bedford, Ebewe Pharma, Eugia Pharma Speclts, Fresenius Kabi Usa, Gland, Kindos, Marchar, Novast Labs, Sagent Pharms Inc, Sandoz, Smith And Nephew, Spectrum Pharms, and Teva Pharms Usa, and is included in forty NDAs. It is available from seventeen suppliers. Additional details are available on the FLUOROURACIL profile page.
The generic ingredient in FLUOROURACIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
The generic ingredient in FLUOROURACIL is fluorouracil. There are fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 215612
| Tradename: | FLUOROURACIL |
| Applicant: | Encube |
| Ingredient: | fluorouracil |
| Patents: | 0 |
Pharmacology for NDA: 215612
| Mechanism of Action | Nucleic Acid Synthesis Inhibitors |
Medical Subject Heading (MeSH) Categories for 215612
Suppliers and Packaging for NDA: 215612
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| FLUOROURACIL | fluorouracil | SOLUTION;TOPICAL | 215612 | ANDA | Encube Ethicals, Inc. | 21922-041 | 21922-041-12 | 1 BOTTLE in 1 CARTON (21922-041-12) / 10 mL in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | 5% | ||||
| Approval Date: | Nov 2, 2023 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
